世界の糖尿病性神経障害治療の市場規模は、2022年に約40億3,000万米ドルに達し、2023年から2030年の予測期間にかけて7.72%以上の健全な成長率で推移すると予測されています。
糖尿病性神経障害治療には、糖尿病による神経障害に伴う症状や合併症の管理を目的としたさまざまな戦略が含まれます。これらの治療法は、痛みの緩和、神経機能の改善、さらなる損傷の予防に重点を置いています。糖尿病性神経障害治療の一般的なアプローチには、薬物療法、生活習慣の改善、代替療法などがあります。糖尿病性神経障害治療市場は、糖尿病有病率の上昇、老人人口の増加、世界の医療支出の増加などの要因により拡大しています。
世界の糖尿病有病率の上昇は、糖尿病性神経障害治療市場の重要な促進要因となっています。糖尿病患者数が増加し続けるにつれ、糖尿病性神経障害の発生率も増加し、治療を必要とする患者数が増加しています。国際糖尿病連合（International Diabetes Federation）のデータによると、2022年には20〜79歳の成人の約5億3,700万人が糖尿病に罹患し、世界全体では10人に1人が罹患していることになります。2030年には6億4,300万人に増加し、2045年には7億8,300万人に増加すると予測されています。加えて、新薬や治療法を発見するための研究開発活動が活発化し、患者中心の医療への関心が高まっていることも、市場開拓に新たな機会をもたらしています。しかし、認知度や教育の不足、薬の副作用などが、2023年から2030年の予測期間を通じて市場の成長を阻害しています。
世界の糖尿病性神経障害治療市場調査で考慮される主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東およびアフリカが含まれます。北アメリカは、洗練された医療インフラと多額の医療費により、糖尿病性神経障害の先進的な治療法を取り入れる環境が整っているため、2022年の市場を独占しました。Abbott社、Pfizer Inc.社、Eli Lilly社、Johnson & Johnson社などの産業大手企業は、この地域に事業基盤を確立しており、市場の拡大をさらに促進しています。さらに、Neuralace Medical社の疼痛性糖尿病性神経障害（PDN）ラベル拡大研究が間もなく完了し、その非侵襲的治療のFDA認可の可能性と相まって、北アメリカの糖尿病性神経障害市場の展望に革命を起こす態勢が整っています。ヨーロッパは、医療インフラの強化や研究イニシアチブの支援に向けた政府資金の増加による積極的な強化などの要因により、予測期間中に最も速い速度で成長すると予想されます。特に、中央欧州糖尿病協会（CEDA）のような非営利団体は、革新的な製品の開発を推進するために製薬会社との協力的な取り組みを行っており、市場の成長にさらに貢献しています。
この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。
このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。
目次
Table of Contents
Chapter 1.Executive Summary
1.1.Market Snapshot
1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1.Diabetic Neuropathy Treatment Market, by Region, 2020-2030 (USD Billion)
1.2.2.Diabetic Neuropathy Treatment Market, by Disorder Type, 2020-2030 (USD Billion)
1.2.3.Diabetic Neuropathy Treatment Market, by Drug Class, 2020-2030 (USD Billion)
1.2.4.Diabetic Neuropathy Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3.Key Trends
1.4.Estimation Methodology
1.5.Research Assumption
Chapter 2.Global Diabetic Neuropathy Treatment Market Definition and Scope
2.1.Objective of the Study
2.2.Market Definition & Scope
2.2.1.Industry Evolution
2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates
Chapter 3.Global Diabetic Neuropathy Treatment Market Dynamics
3.1.Diabetic Neuropathy Treatment Market Impact Analysis (2020-2030)
3.1.1.Market Drivers
3.1.1.1.Rising prevalence of diabetes
3.1.1.2.Rising geriatric population
3.1.1.3. Increasing healthcare expenditure across worldwide
3.1.2.Market Challenges
3.1.2.1.Lack of awareness and education
3.1.2.2.Side effects of medications
3.1.3.Market Opportunities
3.1.3.1.Rising research and development activities to discover new drugs and therapies
3.1.3.2.Growing focus on patient-centric care
Chapter 4.Global Diabetic Neuropathy Treatment Market Industry Analysis
4.1.Porter's 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.2.Porter's 5 Force Impact Analysis
4.3.PEST Analysis
4.3.1.Political
4.3.2.Economical
4.3.3.Social
4.3.4.Technological
4.3.5.Environmental
4.3.6.Legal
4.4.Top investment opportunity
4.5.Top winning strategies
4.6.COVID-19 Impact Analysis
4.7.Disruptive Trends
4.8.Industry Expert Perspective
4.9.Analyst Recommendation & Conclusion
Chapter 5.Global Diabetic Neuropathy Treatment Market, by Disorder Type
5.1.Market Snapshot
5.2.Global Diabetic Neuropathy Treatment Market by Disorder Type, Performance - Potential Analysis
5.3.Global Diabetic Neuropathy Treatment Market Estimates & Forecasts by Disorder Type 2020-2030 (USD Billion)
5.4.Diabetic Neuropathy Treatment Market, Sub Segment Analysis
5.4.1. Peripheral Neuropathy
5.4.2.Autonomic Neuropathy
5.4.3.Proximal Neuropathy
5.4.4.Focal Neuropathy
Chapter 6.Global Diabetic Neuropathy Treatment Market, by Drug Class
6.1.Market Snapshot
6.2.Global Diabetic Neuropathy Treatment Market by Drug Class, Performance - Potential Analysis
6.3.Global Diabetic Neuropathy Treatment Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
6.4.Diabetic Neuropathy Treatment Market, Sub Segment Analysis
6.4.1. Capsaicin
6.4.2.Opioid
6.4.3.Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
6.4.4.Antidepressants
6.4.5.Others
Chapter 7.Global Diabetic Neuropathy Treatment Market, by Distribution Channel
7.1.Market Snapshot
7.2.Global Diabetic Neuropathy Treatment Market by Distribution Channel, Performance - Potential Analysis
7.3.Global Diabetic Neuropathy Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4.Diabetic Neuropathy Treatment Market, Sub Segment Analysis
7.4.1. Hospitals Pharmacies
7.4.2.Retail Pharmacies
7.4.3.Other
Chapter 8.Global Diabetic Neuropathy Treatment Market, Regional Analysis
8.1.Top Leading Countries
8.2.Top Emerging Countries
8.3.Diabetic Neuropathy Treatment Market, Regional Market Snapshot
8.4.North America Diabetic Neuropathy Treatment Market
8.4.1.U.S. Diabetic Neuropathy Treatment Market
8.4.1.1.Disorder Type breakdown estimates & forecasts, 2020-2030
8.4.1.2.Drug Class breakdown estimates & forecasts, 2020-2030
8.4.1.3.Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2.Canada Diabetic Neuropathy Treatment Market
8.5.Europe Diabetic Neuropathy Treatment Market Snapshot
8.5.1.U.K. Diabetic Neuropathy Treatment Market
8.5.2.Germany Diabetic Neuropathy Treatment Market
8.5.3.France Diabetic Neuropathy Treatment Market
8.5.4.Spain Diabetic Neuropathy Treatment Market
8.5.5.Italy Diabetic Neuropathy Treatment Market
8.5.6.Rest of Europe Diabetic Neuropathy Treatment Market
8.6.Asia-Pacific Diabetic Neuropathy Treatment Market Snapshot
8.6.1.China Diabetic Neuropathy Treatment Market
8.6.2.India Diabetic Neuropathy Treatment Market
8.6.3.Japan Diabetic Neuropathy Treatment Market
8.6.4.Australia Diabetic Neuropathy Treatment Market
8.6.5.South Korea Diabetic Neuropathy Treatment Market
8.6.6.Rest of Asia Pacific Diabetic Neuropathy Treatment Market
8.7.Latin America Diabetic Neuropathy Treatment Market Snapshot
8.7.1.Brazil Diabetic Neuropathy Treatment Market
8.7.2.Mexico Diabetic Neuropathy Treatment Market
8.8.Middle East & Africa Diabetic Neuropathy Treatment Market
8.8.1.Saudi Arabia Diabetic Neuropathy Treatment Market
8.8.2.South Africa Diabetic Neuropathy Treatment Market
8.8.3.Rest of Middle East & Africa Diabetic Neuropathy Treatment Market
Chapter 9.Competitive Intelligence
9.1.Key Company SWOT Analysis
9.2.Top Market Strategies
9.3.Company Profiles
9.3.1. Pfizer Inc.
9.3.1.1.Key Information
9.3.1.2.Overview
9.3.1.3.Financial (Subject to Data Availability)
9.3.1.4.Product Summary
9.3.1.5.Recent Developments
9.3.2. Eli Lilly and Company
9.3.3.Johnson & Johnson
9.3.4.Abbott Laboratories
9.3.5.Novo Nordisk A/S
9.3.6.Astellas Pharma Inc.
9.3.7.GlaxoSmithKline plc
9.3.8.Merck & Co., Inc.
9.3.9.Teva Pharmaceutical Industries Ltd.
9.3.10.Boehringer Ingelheim International GmbH
Chapter 10.Research Process
10.1.Research Process
10.1.1.Data Mining
10.1.2.Analysis
10.1.3.Market Estimation
10.1.4.Validation
10.1.5.Publishing
10.2.Research Attributes
10.3.Research Assumption
LIST OF TABLES
TABLE 1.Global Diabetic Neuropathy Treatment Market, report scope
TABLE 2.Global Diabetic Neuropathy Treatment Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3.Global Diabetic Neuropathy Treatment Market estimates & forecasts by Disorder Type 2020-2030 (USD Billion)
TABLE 4.Global Diabetic Neuropathy Treatment Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
TABLE 5.Global Diabetic Neuropathy Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 6.Global Diabetic Neuropathy Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7.Global Diabetic Neuropathy Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8.Global Diabetic Neuropathy Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9.Global Diabetic Neuropathy Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10.Global Diabetic Neuropathy Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11.Global Diabetic Neuropathy Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12.Global Diabetic Neuropathy Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13.Global Diabetic Neuropathy Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14.Global Diabetic Neuropathy Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15.Global Diabetic Neuropathy Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16.U.S. Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17.U.S. Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18.U.S. Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19.Canada Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20.Canada Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21.Canada Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22.UK Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23.UK Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24.UK Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25.Germany Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26.Germany Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27.Germany Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28.France Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29.France Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30.France Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31.Italy Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32.Italy Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33.Italy Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34.Spain Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35.Spain Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36.Spain Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37.RoE Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38.RoE Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39.RoE Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40.China Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41.China Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42.China Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43.India Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44.India Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45.India Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46.Japan Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47.Japan Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48.Japan Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49.South Korea Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50.South Korea Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51.South Korea Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52.Australia Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53.Australia Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54.Australia Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55.RoAPAC Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56.RoAPAC Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57.RoAPAC Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58.Brazil Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59.Brazil Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60.Brazil Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61.Mexico Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62.Mexico Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63.Mexico Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64.RoLA Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65.RoLA Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66.RoLA Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67.Saudi Arabia Diabetic Neuropathy Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68.South Africa Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69.RoMEA Diabetic Neuropathy Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70.List of secondary sources, used in the study of global Diabetic Neuropathy Treatment Market
TABLE 71.List of primary sources, used in the study of global Diabetic Neuropathy Treatment Market
TABLE 72.Years considered for the study
TABLE 73.Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1.Global Diabetic Neuropathy Treatment Market, research methodology
FIG 2.Global Diabetic Neuropathy Treatment Market, Market estimation techniques
FIG 3.Global Market size estimates & forecast methods
FIG 4.Global Diabetic Neuropathy Treatment Market, key trends 2022
FIG 5.Global Diabetic Neuropathy Treatment Market, growth prospects 2023-2030
FIG 6.Global Diabetic Neuropathy Treatment Market, porters 5 force model
FIG 7.Global Diabetic Neuropathy Treatment Market, pest analysis
FIG 8.Global Diabetic Neuropathy Treatment Market, value chain analysis
FIG 9.Global Diabetic Neuropathy Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 10.Global Diabetic Neuropathy Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 11.Global Diabetic Neuropathy Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 12.Global Diabetic Neuropathy Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 13.Global Diabetic Neuropathy Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 14.Global Diabetic Neuropathy Treatment Market, regional snapshot 2020 & 2030
FIG 15.North America Diabetic Neuropathy Treatment Market 2020 & 2030 (USD Billion)
FIG 16.Europe Diabetic Neuropathy Treatment Market 2020 & 2030 (USD Billion)
FIG 17.Asia pacific Diabetic Neuropathy Treatment Market 2020 & 2030 (USD Billion)
FIG 18.Latin America Diabetic Neuropathy Treatment Market 2020 & 2030 (USD Billion)
FIG 19.Middle East & Africa Diabetic Neuropathy Treatment Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
